![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C12N 9/64 | (2006.01) |
(11) | Number of the document | 3411478 |
(13) | Kind of document | T |
(96) | European patent application number | 17705236.2 |
Date of filing the European patent application | 2017-01-31 | |
(97) | Date of publication of the European application | 2018-12-12 |
(45) | Date of publication and mention of the grant of the patent | 2022-06-08 |
(46) | Date of publication of the claims translation | 2022-09-26 |
(86) | Number | PCT/US2017/015879 |
Date | 2017-01-31 |
(87) | Number | WO 2017/136358 |
Date | 2017-08-10 |
(30) | Number | Date | Country code |
201662289696 P | 2016-02-01 | US | |
201662409739 P | 2016-10-18 | US |
(72) |
TAN, Siyuan , US
LIU, Tongyao , US
|
(73) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham, MA 02451,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Optimizuoti VIII faktoriaus genai |
OPTIMIZED FACTOR VIII GENES |
Payment date | Validity (years) | Amount | |
2024-12-19 | 9 | 208.00 EUR |
2026-01-31 |